261 related articles for article (PubMed ID: 22280422)
1. Fabry disease cardiomyopathy: from genes to clinical manifestations.
Kertész AB; Édes I
Curr Pharm Biotechnol; 2012 Oct; 13(13):2477-84. PubMed ID: 22280422
[TBL] [Abstract][Full Text] [Related]
2. [Fabry-Anderson disease: current state of knowledge].
Vega-Vega O; Pérez-Gutiérrez A; Correa-Rotter R
Rev Invest Clin; 2011; 63(3):314-21. PubMed ID: 21888295
[TBL] [Abstract][Full Text] [Related]
3. Kidney involvement in Anderson-Fabry disease.
Meroni M; Sessa A; Battini G; Tazzari S; Torri Tarelli L
Contrib Nephrol; 1997; 122():178-84. PubMed ID: 9399062
[No Abstract] [Full Text] [Related]
4. [Fabry disease].
Subran B; Montagner C; London J; Lidove O; Mauhin W
Rev Prat; 2020 May; 70(5):537-540. PubMed ID: 33058644
[TBL] [Abstract][Full Text] [Related]
5. Enzyme replacement therapy partially prevents invariant Natural Killer T cell deficiency in the Fabry disease mouse model.
Macedo MF; Quinta R; Pereira CS; Sa Miranda MC
Mol Genet Metab; 2012 May; 106(1):83-91. PubMed ID: 22425450
[TBL] [Abstract][Full Text] [Related]
6. Progress in the understanding and treatment of Fabry disease.
Miller JJ; Kanack AJ; Dahms NM
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129437. PubMed ID: 31526868
[TBL] [Abstract][Full Text] [Related]
7. Anderson-Fabry disease and the heart.
O'Mahony C; Elliott P
Prog Cardiovasc Dis; 2010; 52(4):326-35. PubMed ID: 20109602
[TBL] [Abstract][Full Text] [Related]
8. [Diffuse hyperkeratotic papules of the lower abdomen and genital region in a 38-year old male patient].
Kuntz T; Mitrakos G; Koushk-Jalali B; Oellig F; Eismann L; Tigges C; Kreuter A
Internist (Berl); 2020 Jun; 61(6):621-625. PubMed ID: 32367302
[TBL] [Abstract][Full Text] [Related]
9. Genetics and Gene Therapy of Anderson-Fabry Disease.
Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A
Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309
[TBL] [Abstract][Full Text] [Related]
10. Recent advances and novel treatments for sphingolipidoses.
Arenz C
Future Med Chem; 2017 Sep; 9(14):1687-1700. PubMed ID: 28857617
[TBL] [Abstract][Full Text] [Related]
11. Expression of genes and their responses to enzyme replacement therapy in a Fabry disease mouse model.
Park ES; Choi JO; Park JW; Lee MH; Park HY; Jung SC
Int J Mol Med; 2009 Sep; 24(3):401-7. PubMed ID: 19639234
[TBL] [Abstract][Full Text] [Related]
12. Fabry Disease and the Heart: A Comprehensive Review.
Azevedo O; Cordeiro F; Gago MF; Miltenberger-Miltenyi G; Ferreira C; Sousa N; Cunha D
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922740
[TBL] [Abstract][Full Text] [Related]
13. Fabry disease.
Germain DP
Orphanet J Rare Dis; 2010 Nov; 5():30. PubMed ID: 21092187
[TBL] [Abstract][Full Text] [Related]
14. The kidney in Fabry's disease.
Pisani A; Visciano B; Imbriaco M; Di Nuzzi A; Mancini A; Marchetiello C; Riccio E
Clin Genet; 2014 Oct; 86(4):301-9. PubMed ID: 24645664
[TBL] [Abstract][Full Text] [Related]
15. A novel small insertion mutation, C.1030_1031ins (T) in α-galactosidase A leads to renal variant fabry disease.
Choi JS; Kim CS; Park JW; Bae EH; Ma SK; Choi YD; Kim GH; Yoo HW; Kim SW
Ren Fail; 2012; 34(3):390-3. PubMed ID: 22260214
[TBL] [Abstract][Full Text] [Related]
16. Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage.
Wang RY; Abe JT; Cohen AH; Wilcox WR
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S369-74. PubMed ID: 18937048
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous complications of Anderson-Fabry disease.
Giuseppe P; Daniele R; Rita BM
Curr Pharm Des; 2013; 19(33):6031-6. PubMed ID: 23448454
[TBL] [Abstract][Full Text] [Related]
18. Human α-Galactosidase A Mutants: Priceless Tools to Develop Novel Therapies for Fabry Disease.
Modrego A; Amaranto M; Godino A; Mendoza R; Barra JL; Corchero JL
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204583
[TBL] [Abstract][Full Text] [Related]
19. [Fabry disease (alpha-galactosidase deficiency)].
Okumiya T; Sakuraba H
Nihon Rinsho; 1995 Dec; 53(12):2952-9. PubMed ID: 8577042
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic and functional correction along with long-term enzyme secretion from transduced bone marrow hematopoietic stem/progenitor and stromal cells derived from patients with Fabry disease.
Takenaka T; Hendrickson CS; Tworek DM; Tudor M; Schiffmann R; Brady RO; Medin JA
Exp Hematol; 1999 Jul; 27(7):1149-59. PubMed ID: 10390190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
